Tsutomu Yasutake

1.3k citations

25 papers · 1.1k indexed · h-index 17

Epidemiology top 10%
Molecular Biology
Hepatology top 5%
Endocrinology, Diabetes and Metabolism top 5%
Cancer Research top 10%

Co-authors: Toshihiko Mizuta Iwata Ozaki Yuichiro Eguchi Kyosuke Yamamoto Hao Zhang Seiji Kawazoe Yasushi Ide Shinpei Matsuhashi
Topics: Liver Disease Diagnosis and Treatment (12 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Hepatitis C virus research (3 papers)
Cited by: Hepatology Endocrinology, Diabetes and Metabolism Epidemiology
Journals: Hepatology Cancer Oncogene
Partner nations: Japan United States China

In The Last Decade

Tsutomu Yasutake

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Tsutomu Yasutake

Since Specialization

Citations

This map shows the geographic impact of Tsutomu Yasutake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsutomu Yasutake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsutomu Yasutake more than expected).

Fields of papers citing papers by Tsutomu Yasutake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsutomu Yasutake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsutomu Yasutake. The network helps show where Tsutomu Yasutake may publish in the future.

Co-authorship network of co-authors of Tsutomu Yasutake

This figure shows the co-authorship network connecting the top 25 collaborators of Tsutomu Yasutake. A scholar is included among the top collaborators of Tsutomu Yasutake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsutomu Yasutake. Tsutomu Yasutake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablation. 2010 ·PubMed ·Keisuke Ario,Toshihiko Mizuta,Yuichiro Eguchi,Yasunori Kawaguchi,Noriko Oza,Takumi Akiyama,Shinji Iwane,Kazuhiro Takahashi,Tsutomu Yasutake,Iwata Ozaki,Kazuma Fujimoto	1
2	Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation 2009 ·Liver International ·Yuichiro Eguchi,Toshihiko Mizuta,(unknown),Yoichiro Kitajima,Noriko Oza,Shunya Nakashita,Megumi Hara,Shinji Iwane,Kazuhiro Takahashi,Takumi Akiyama,Keisuke Ario,Yasunori Kawaguchi,Tsutomu Yasutake,Ryuichi Iwakiri,Iwata Ozaki,Akitaka Hisatomi,Takahisa Eguchi,Naofumi Ono,Kazuma Fujimoto	28
3	Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population 2009 ·Carcinogenesis ·Takeshi Imaizumi,Yasuki Higaki,Megumi Hara,Tohru Sakamoto,Mikako Horita,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,(unknown),Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi,Shin‐ei Kudo,Kenichi A. Tanaka	32
4	Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non‐alcoholic fatty liver disease, but not in females 2008 ·Journal of Gastroenterology and Hepatology ·(unknown),Yuichiro Eguchi,Takahisa Eguchi,(unknown),Noriko Oza,Shunya Nakashita,Yoichiro Kitajima,S Kuroki,Iwata Ozaki,Yasunori Kawaguchi,Yasushi Ide,Tsutomu Yasutake,Ryuichi Iwakiri,Toshihiko Mizuta,Naofumi Ono,Kazuma Fujimoto	35
5	Interaction between interleukin-1β −31T/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese 2008 ·Cancer Letters ·Tatsuhiko Sakamoto,Yasuki Higaki,Megumi Hara,Masayoshi Ichiba,Mikako Horita,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,Iwata Ozaki,Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi,Keitaro Tanaka	22
6	Case–control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese 2007 ·Cancer Science ·Megumi Hara,Keitaro Tanaka,Tatsuhiko Sakamoto,Yasuki Higaki,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,Iwata Ozaki,Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi	26
7	High‐dose vitamins E and C supplementation prevents ribavirin‐induced hemolytic anemia in patients with chronic hepatitis C 2007 ·Hepatology Research ·Yasunori Kawaguchi,Toshihiko Mizuta,Kazuhiro Takahashi,Shinji Iwane,Keisuke Ario,(unknown),(unknown),Yuichiro Eguchi,Tsutomu Yasutake,(unknown),Seiji Kawazoe,Noriko Fukushima,Iwata Ozaki,Kazuma Fujimoto	2
8	Paternal transmission and slow elimination of mutant alleles associated with late-onset ornithine transcarbamylase deficiency in male patients 2007 ·Journal of Human Genetics ·Sanae Numata,(unknown),Yasuki Maeno,(unknown),Yoriko Watanabe,(unknown),Takashi Yanagawa,Satoshi Takenaka,Toshiro Inoue,(unknown),(unknown),Tsutomu Yasutake,Toshihiko Mizuta,Makoto Yoshino	8
9	Menatetrenone, a Vitamin K2 Analogue, Inhibits Hepatocellular Carcinoma Cell Growth by Suppressing Cyclin D1 Expression through Inhibition of Nuclear Factor κB Activation 2007 ·Clinical Cancer Research ·Iwata Ozaki,Hao Zhang,Toshihiko Mizuta,Yasushi Ide,Yuichiro Eguchi,Tsutomu Yasutake,Toshiyuki Sakamaki,Richard G. Pestell,Kyosuke Yamamoto	63
10	The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment 2006 ·Cancer ·Toshihiko Mizuta,Iwata Ozaki,Yuichiro Eguchi,Tsutomu Yasutake,Seiji Kawazoe,Kazuma Fujimoto,Kyosuke Yamamoto	98
11	hOGG1 Ser326Cys Polymorphism and Risk of Hepatocellular Carcinoma among Japanese 2006 ·Journal of Epidemiology ·Tatsuhiko Sakamoto,Yasuki Higaki,Megumi Hara,Masayoshi Ichiba,Mikako Horita,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,Iwata Ozaki,Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi,Keitaro Tanaka	17
12	Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease 2006 ·Journal of Gastroenterology ·Yuichiro Eguchi,Takahisa Eguchi,Toshihiko Mizuta,Yasushi Ide,Tsutomu Yasutake,Ryuichi Iwakiri,(unknown),Iwata Ozaki,Kei Yamamoto,(unknown),(unknown),(unknown),(unknown)	230
13	Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case‐control study in Japan 2006 ·Cancer Science ·Keitaro Tanaka,Megumi Hara,Tatsuhiko Sakamoto,Yasuki Higaki,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,Iwata Ozaki,Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi	56
14	Influence of alcohol consumption and gene polymorphisms ofADH2andALDH2on hepatocellular carcinoma in a Japanese population 2005 ·International Journal of Cancer ·Tatsuhiko Sakamoto,Megumi Hara,Yasuki Higaki,Masayoshi Ichiba,Mikako Horita,Toshihiko Mizuta,Yuichiro Eguchi,Tsutomu Yasutake,Iwata Ozaki,Kyosuke Yamamoto,(unknown),Seiji Kawazoe,Hirohisa Shigematsu,Shunzo Koizumi,Keitaro Tanaka	77
15	A case presenting with impaired vision due to cortical blindness as a complication of hepatic encephalopathy 2004 ·Kanzo ·Yuichiro Eguchi,Shinji Iwane,(unknown),(unknown),Tsutomu Yasutake,Toshihiko Mizuta,Iwata Ozaki,(unknown),Kyosuke Yamamoto	3
16	Transforming growth factor‐β1‐induced apoptosis is blocked by β1‐integrin‐mediated mitogen‐activated protein kinase activation in human hepatoma cells 2004 ·Cancer Science ·Hao Zhang,Iwata Ozaki,Toshihiko Mizuta,Toru Yoshimura,Sachiko Matsuhashi,Yuichiro Eguchi,Tsutomu Yasutake,Akitaka Hisatomi,Takahiro Sakai,Kyosuke Yamamoto	30
17	The Relationship between Insulin Resistance and Polymorphisms of the Endothelial Nitric Oxide Synthase Gene in Patients with Coronary Artery Disease. 2003 ·Journal of Atherosclerosis and Thrombosis ·Toru Yoshimura,Akitaka Hisatomi,Susumu Kajihara,Tsutomu Yasutake,(unknown),Toshihiko Mizuta,Iwata Ozaki,Toshinori Utsunomiya,Kyosuke Yamamoto	21
18	Association of the Pro90Ser CD36 mutation with elevated free fatty acid concentrations but not with insulin resistance syndrome in Japanese 2001 ·Clinica Chimica Acta ·Susumu Kajihara,Akitaka Hisatomi,Yoko Ogawa,Tsutomu Yasutake,(unknown),(unknown),Toshihiko Mizuta,Iwata Ozaki,Noriyuki Iwamoto,Kyosuke Yamamoto	17
19	Gln27Glu β2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver 2001 ·Clinica Chimica Acta ·Noriyuki Iwamoto,Yoko Ogawa,Susumu Kajihara,Akitaka Hisatomi,Tsutomu Yasutake,Toru Yoshimura,Toshihiko Mizuta,(unknown),Iwata Ozaki,Kyosuke Yamamoto	41
20	Familial Pelger-Huet Anomaly Accompanied by Tuberculosis and Complicated by Acute Polyarthritis 1995 ·Scandinavian Journal of Rheumatology ·Noriaki Suzuki,Tsutomu Yasutake,Osamu Ushiyama,(unknown),Akio Ohta,M. Yamaguchi	3

About Tsutomu Yasutake

Tsutomu Yasutake is a scholar working on Hepatology, Epidemiology and Immunology and Allergy, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Hepatitis C virus research (3 papers). The work is most often cited by research in Hepatology (236 citations), Endocrinology, Diabetes and Metabolism (231 citations) and Epidemiology (460 citations). Tsutomu Yasutake has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Toshihiko Mizuta, Iwata Ozaki, Yuichiro Eguchi, Kyosuke Yamamoto, Hao Zhang, Seiji Kawazoe, Yasushi Ide, Shinpei Matsuhashi, Hiroshi Hamajima and Takahisa Eguchi. Their work appears in journals such as Hepatology, Cancer and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact